Heparin-Induced Thrombocytopenia

Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia

Pharmacogenomics of Heparin-Induced Thrombocytopenia

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis